CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxCheap semaglutide and nationwide coverage, with a tirzepatide markup and no LegitScript listing.
Visit Live VitalCoreAge Rx takes it with a higher Verdict Score — 94/100 to 83/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Live Vital still earns its place — semaglutide-first shoppers on a budget who want nationwide access.
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
| Metric | CoreAge Rx | Live Vital |
|---|---|---|
| Verdict Score | 94/100 | 83/100 |
| Grade | A | B |
| Semaglutide | $149/mo | $99/mo |
| Tirzepatide | $349/mo | $183/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | No | No |
What we like
The caveats
What we like
The caveats
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Semaglutide-first shoppers on a budget who want nationwide access.
Visit Live Vital Read the full Live Vital review →Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Live Vital does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.